Radiation Oncology Basics — MCQs

Q: What is the management of osteoradionecrosis?

All of the above. **Explanation:** Osteoradionecrosis (ORN) is a serious late complication of radiotherapy, most commonly affecting the mandible. It is characterized by bone death due to radiation-induced **hypocellularity, hypovascularity, and hypoxia (Marx’s 3H theory)**, leading to non-healing exposed bone. The management of ORN is multifaceted, involving conservative, medical, and surgical interventions: 1. **Hyperbaric Oxygen (HBO):** This is a cornerstone of treatment. It increases dissolved oxygen levels in tissues, stimulating angiogenesis and fibroblastic activity, which helps reverse the radiation-induced hypoxic state. 2. **Removal of Sequestrum (Sequestrectomy):** Surgical intervention is required to remove necrotic, infected bone (sequestrum) that acts as a nidus for infection and prevents healing. 3. **Fluoride Application:** Preventive and supportive care is vital. Radiation damages salivary glands (xerostomia), increasing the risk of radiation caries. Daily topical fluoride application is essential to maintain dental integrity and prevent odontogenic infections that could trigger or worsen ORN. **Why "All of the above" is correct:** Effective management requires a combination of improving tissue oxygenation (HBO), surgical debridement of dead bone, and strict oral hygiene/caries prevention (Fluoride) to arrest the progression of the disease. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Mandible (due to lower vascularity compared to the maxilla). * **Marx’s Protocol:** Often involves 20–30 sessions of HBO before surgery and 10 sessions after. * **PENTOCLO Protocol:** A newer medical management involving Pentoxifylline, Tocopherol (Vitamin E), and Clodronate. * **Prevention:** All necessary dental extractions should ideally be completed **at least 2–3 weeks before** starting radiotherapy.

Q: Osteoradionecrosis most commonly results from which combination of factors?

Radiation, trauma, and infection. ### Explanation **Osteoradionecrosis (ORN)** is a serious complication of radiation therapy, most commonly affecting the mandible. The pathophysiology is traditionally explained by the **Marx Theory (3-H Principle)**: Hypoxia, Hypocellularity, and Hypovascularity. **1. Why Option B is Correct:** The classic triad responsible for the development of ORN is **Radiation, Trauma, and Infection**. * **Radiation:** Causes endarteritis obliterans, leading to a permanent state of hypoxia and reduced bone vitality. * **Trauma:** Often in the form of a tooth extraction or ill-fitting dentures, it acts as the inciting event that breaks the mucosal barrier. * **Infection:** Once the barrier is breached, secondary infection and microbial colonization occur in the non-vital bone, leading to non-healing necrosis. **2. Why Other Options are Incorrect:** While Options A and C contain the same three elements, the sequence in Option B reflects the **chronological pathophysiology** generally accepted in clinical oncology: Radiation therapy creates the vulnerable environment, Trauma provides the trigger, and Infection complicates the healing process. In the context of NEET-PG, the "Radiation-Trauma-Infection" sequence is the standard academic description of the triad. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most Common Site:** The **Mandible** (due to its higher bone density and lower vascularity compared to the maxilla). * **Marx Classification:** Used to stage ORN based on response to Hyperbaric Oxygen (HBO) therapy. * **Prevention:** All necessary dental extractions should be completed at least **2–3 weeks before** starting radiation therapy. * **Treatment:** Management includes antibiotics, debridement, and **Hyperbaric Oxygen (HBO)** therapy to stimulate angiogenesis.

Q: What is the standard treatment of whole-brain radiotherapy (WB) for brain Metastasis?

30 grays (Gy) in 10 fractions. ### Explanation **Standard Treatment Protocol** Whole-brain radiotherapy (WBRT) is a cornerstone in the palliative management of multiple brain metastases. The goal is to achieve a balance between tumor control and the preservation of neurocognitive function. The **standard fractionation schedule is 30 Gy delivered in 10 fractions** (3 Gy per fraction) over two weeks. This regimen is preferred because it provides an optimal therapeutic ratio, effectively reducing intracranial pressure and neurological symptoms while minimizing long-term radiation-induced leukoencephalopathy. **Analysis of Options** * **Option A (20 Gy in 10 fractions):** This dose is sub-therapeutic for most solid tumor metastases. While it uses a standard number of fractions, the total dose is insufficient for durable local control. * **Option C (30 Gy in 5 fractions):** This represents "hypofractionation" (6 Gy per fraction). While sometimes used in patients with a very poor prognosis (short life expectancy), it carries a significantly higher risk of acute and late neurological toxicity due to the high dose per fraction. * **Option D (15 Gy in 10 fractions):** This dose is far below the clinical threshold required to treat metastatic disease and is not a recognized standard protocol. **High-Yield Clinical Pearls for NEET-PG** * **Indications:** WBRT is typically indicated for patients with >3–4 metastases or those not suitable for Stereotactic Radiosurgery (SRS). * **Hippocampal Sparing:** Modern WBRT techniques often use "Hippocampal Sparing" to reduce memory decline. * **Steroid Adjunct:** Dexamethasone is usually administered alongside WBRT to reduce vasogenic edema caused by the tumors and the radiation itself. * **Alternative Schedule:** 20 Gy in 5 fractions is another accepted short-course regimen for patients with poor performance status.

Q: Maximum damage to the skin is caused by which type of radiation therapy?

Orthovoltage X-ray. **Explanation:** The degree of skin damage in radiation therapy is primarily determined by the **"Skin Sparing Effect."** This phenomenon depends on the energy of the radiation beam and the depth at which the maximum dose ($D_{max}$) is deposited. **Why Orthovoltage is the Correct Answer:** Orthovoltage X-rays operate at a relatively low energy range (typically **200–500 kV**). Because of this low energy, the maximum dose ($D_{max}$) is deposited almost immediately at the **skin surface**. Since the skin receives 100% of the prescribed dose, it suffers the most significant damage, leading to side effects like erythema, desquamation, and permanent scarring. **Analysis of Incorrect Options:** * **Supervoltage (500–1000 kV) & Megavoltage (>1 MV) X-rays:** As the energy of the X-ray increases, the $D_{max}$ shifts deeper into the tissues (e.g., for a 6 MV beam, $D_{max}$ is at 1.5 cm). This results in a lower dose at the surface, providing a significant skin-sparing effect. * **Cobalt-60:** This is a form of megavoltage therapy (average energy 1.25 MeV). Its $D_{max}$ occurs at **0.5 cm** below the skin surface, meaning it spares the skin significantly more than orthovoltage. **High-Yield Clinical Pearls for NEET-PG:** * **Skin Sparing Effect:** The higher the energy of the photon beam, the deeper the $D_{max}$, and the greater the skin sparing. * **$D_{max}$ Values to Remember:** * **Orthovoltage:** 0.0 cm (Surface) * **Cobalt-60:** 0.5 cm * **4 MV:** 1.0 cm * **6 MV:** 1.5 cm * **10 MV:** 2.5 cm * **Clinical Use:** Orthovoltage is now rarely used except for very superficial lesions (e.g., skin cancers) precisely because it lacks skin sparing.

Q: Brachytherapy is an internal radiation therapy procedure for treating tumors. Which of the following isotopes is NOT used in brachytherapy?

Iodine-131. **Explanation:** The core principle of **Brachytherapy** is the placement of radioactive sources either inside or in close proximity to the tumor. This allows for a high dose of radiation to the target tissue with a rapid dose fall-off, sparing surrounding healthy organs. **Why Iodine-131 is the correct answer:** Iodine-131 (I-131) is primarily used in **Systemic Radionuclide Therapy**, not brachytherapy. It is administered orally or intravenously (unsealed source) for the treatment of differentiated thyroid cancer and hyperthyroidism. Because it is distributed through the bloodstream to target thyroid tissue globally, it does not fit the definition of "brachy" (short-distance) localized source therapy. **Analysis of other options:** * **Iridium-192 (Option D):** The most commonly used isotope in modern clinical brachytherapy, especially for High Dose Rate (HDR) procedures (e.g., cervical and breast cancer). It has a high specific activity and a half-life of ~74 days. * **Iodine-125 (Option A):** A low-energy gamma emitter used for **permanent seed implants**, most commonly in prostate cancer (LDR brachytherapy). * **Cesium-137 (Option C):** Historically the gold standard for Low Dose Rate (LDR) brachytherapy in cervical cancer (e.g., Manchester system). While largely replaced by Iridium-192, it remains a classic brachytherapy isotope. **High-Yield Clinical Pearls for NEET-PG:** * **Cobalt-60:** Used in Teletherapy (Bhabhatron/Gamma Knife) and occasionally in HDR brachytherapy. * **Palladium-103:** Another common isotope for permanent prostate seeds. * **Strontium-90:** A pure beta emitter used for superficial brachytherapy (e.g., pterygium in the eye). * **Gold-198:** Historically used as permanent grains/seeds.

Q: Which of the following is the most radiosensitive ovarian tumor?

Dysgerminoma. **Explanation:** **Dysgerminoma** is the most common malignant germ cell tumor of the ovary and is characterized by its extreme **radiosensitivity**. This property is a hallmark of germ cell tumors (similar to its male counterpart, the seminoma). While surgery is the primary treatment to preserve fertility, radiotherapy is highly effective in treating recurrences or metastatic disease because these cells undergo rapid apoptosis when exposed to ionizing radiation. **Analysis of Incorrect Options:** * **Dermoid Cyst (Mature Cystic Teratoma):** This is a benign germ cell tumor containing mature tissues (hair, teeth, sebum). These mature tissues are differentiated and **radioresistant**. * **Serous Cystadenoma:** This is a benign epithelial tumor. Epithelial tumors, in general, are less radiosensitive than germ cell tumors, and benign versions do not require radiation therapy. * **Endodermal Sinus Tumor (Yolk Sac Tumor):** While this is a malignant germ cell tumor, it is highly aggressive and primarily treated with **chemotherapy** (BEP regimen). It is not as exquisitely radiosensitive as Dysgerminoma. **Clinical Pearls for NEET-PG:** * **Tumor Marker:** Dysgerminoma is associated with elevated **LDH** (and occasionally hCG), whereas Endodermal Sinus Tumor is associated with high **AFP**. * **Radiosensitivity Rule:** In the context of "Most Radiosensitive," always look for **Dysgerminoma** (Ovary), **Seminoma** (Testis), or **Ewing’s Sarcoma** (Bone). * **Histology:** Dysgerminoma shows large cells with clear cytoplasm and central nuclei, separated by fibrous septa containing lymphocytes.

Q: Mould therapy is used in the treatment of:

Skin cancer. **Explanation:** **Mould therapy** is a form of **surface brachytherapy** where radioactive sources are placed in a customized applicator (the "mould") that is applied directly to the surface of the body. 1. **Why Skin Cancer is Correct:** Mould therapy is specifically designed for treating superficial lesions. The radioactive sources (commonly Iridium-192 or Cesium-137) are held at a short, fixed distance from the skin. This allows for a high dose of radiation to be delivered to the tumor while ensuring a rapid dose fall-off, which protects the deeper, healthy underlying tissues. It is most commonly used for cancers of the **skin (e.g., Basal Cell Carcinoma, Squamous Cell Carcinoma)**, lip, or hard palate. 2. **Why Other Options are Incorrect:** * **Pelvic and Prostate Cancer:** These involve deep-seated tumors. They are typically treated with **Intracavitary brachytherapy** (e.g., cervical cancer), **Interstitial brachytherapy** (needles inserted into the prostate), or External Beam Radiation Therapy (EBRT). Moulds cannot reach these depths. * **Lung Cancer:** This requires EBRT or occasionally **Intraluminal brachytherapy** (via bronchoscopy). A surface mould would be ineffective for internal thoracic structures. **High-Yield Clinical Pearls for NEET-PG:** * **Brachytherapy Types:** * **Surface (Moulds):** Skin, ear, eye. * **Interstitial:** Breast, Prostate, Tongue (using needles/wires). * **Intracavitary:** Cervix, Endometrium (using Tandem and Ovoids). * **Intraluminal:** Esophagus, Bronchus. * **Inverse Square Law:** The rapid dose fall-off in mould therapy is governed by the inverse square law, making it ideal for superficial treatment. * **Customization:** Moulds are often made of dental acrylic or thermoplastic materials to fit the patient's specific anatomy perfectly.

Q: Which radiation therapy modality utilizes the concept of "remote afterloading"?

Brachytherapy. **Explanation:** **Brachytherapy** is the correct answer because it involves placing radioactive sources directly inside or in close proximity to the target tissue. **Remote Afterloading** is a safety technique used in modern brachytherapy (especially High Dose Rate or HDR) where the radioactive source is stored in a shielded safe and mechanically driven through applicators into the patient via computerized remote control. This system minimizes radiation exposure to healthcare personnel, as the source is only "loaded" once the staff has left the room. **Analysis of Incorrect Options:** * **Proton Beam Therapy:** A type of external beam radiotherapy (EBRT) using heavy particles (protons). It is characterized by the "Bragg Peak," allowing for precise dose deposition but does not involve afterloading. * **Electron Beam Therapy:** A form of EBRT used for superficial tumors (e.g., skin cancer). Electrons have a limited range in tissue and do not require internal source loading. * **Cyberknife Therapy:** A form of robotic Stereotactic Radiosurgery (SRS). It delivers high-dose EBRT from many different angles using a miniature linear accelerator mounted on a robotic arm. **High-Yield Clinical Pearls for NEET-PG:** * **Inverse Square Law:** Brachytherapy follows this principle, where the dose falls off rapidly as distance from the source increases, sparing surrounding healthy organs. * **Common Isotopes:** Iridium-192 (most common for HDR afterloading), Cesium-137, and Iodine-125 (permanent seeds for prostate). * **Manchester System:** A classic dosage system used in cervical brachytherapy (Point A and Point B). * **Safety:** Remote afterloading has effectively replaced "manual loading," making brachytherapy significantly safer for oncology nurses and therapists.

Q: Hyperfractionated radiotherapy is primarily used in which of the following conditions?

Lung cancer. **Explanation:** **Hyperfractionated radiotherapy** involves delivering a higher total dose of radiation by using smaller-than-standard doses (fractions) multiple times a day (usually twice). The primary goal is to exploit the difference in repair capacity between rapidly dividing tumor cells and late-responding normal tissues. 1. **Why Lung Cancer is Correct:** Small Cell Lung Cancer (SCLC) is the classic indication for hyperfractionation (e.g., the Turrisi regimen). Because lung tumors have a high growth fraction, giving two fractions a day minimizes "tumor repopulation" during the treatment course. Smaller doses per fraction also spare late-responding normal tissues like the lungs and spinal cord, allowing for a higher total curative dose. 2. **Why Other Options are Incorrect:** * **Melanomas and Soft Tissue Sarcomas:** These are considered **radioresistant** tumors with a low alpha/beta ratio. They respond better to **Hypofractionation** (larger doses per fraction given fewer times). Large fractions are needed to overcome their inherent repair mechanisms and slow cell cycling. * **All of the above:** Incorrect because the biological rationale for hyperfractionation (sparing late tissues while hitting fast-growing tumors) does not apply to slow-growing, radioresistant sarcomas or melanomas. **Clinical Pearls for NEET-PG:** * **Hyperfractionation:** Increased number of fractions, decreased dose per fraction, total dose increased. Best for **rapidly proliferating tumors** (e.g., SCLC, Head and Neck cancers). * **Hypofractionation:** Decreased number of fractions, increased dose per fraction. Best for **slowly proliferating tumors** (e.g., Prostate, Melanoma, Breast). * **Accelerated Fractionation:** Reducing the overall treatment time without changing the dose per fraction (to counter rapid tumor repopulation).

Radiation Oncology Basics Indian Medical PG Practice Questions and MCQs

Question 1: What is the management of osteoradionecrosis?

A. Hyperbaric oxygen
B. Removal of sequestrum
C. Fluoride application
D. All of the above (Correct Answer)

Explanation: **Explanation:** Osteoradionecrosis (ORN) is a serious late complication of radiotherapy, most commonly affecting the mandible. It is characterized by bone death due to radiation-induced **hypocellularity, hypovascularity, and hypoxia (Marx’s 3H theory)**, leading to non-healing exposed bone. The management of ORN is multifaceted, involving conservative, medical, and surgical interventions: 1. **Hyperbaric Oxygen (HBO):** This is a cornerstone of treatment. It increases dissolved oxygen levels in tissues, stimulating angiogenesis and fibroblastic activity, which helps reverse the radiation-induced hypoxic state. 2. **Removal of Sequestrum (Sequestrectomy):** Surgical intervention is required to remove necrotic, infected bone (sequestrum) that acts as a nidus for infection and prevents healing. 3. **Fluoride Application:** Preventive and supportive care is vital. Radiation damages salivary glands (xerostomia), increasing the risk of radiation caries. Daily topical fluoride application is essential to maintain dental integrity and prevent odontogenic infections that could trigger or worsen ORN. **Why "All of the above" is correct:** Effective management requires a combination of improving tissue oxygenation (HBO), surgical debridement of dead bone, and strict oral hygiene/caries prevention (Fluoride) to arrest the progression of the disease. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Mandible (due to lower vascularity compared to the maxilla). * **Marx’s Protocol:** Often involves 20–30 sessions of HBO before surgery and 10 sessions after. * **PENTOCLO Protocol:** A newer medical management involving Pentoxifylline, Tocopherol (Vitamin E), and Clodronate. * **Prevention:** All necessary dental extractions should ideally be completed **at least 2–3 weeks before** starting radiotherapy.

Question 2: Prophylactic cranial irradiation is indicated in the treatment of all of the following conditions, except:

A. Small cell carcinoma of the lung
B. Acute lymphoblastic leukemia
C. Hodgkin's lymphoma (Correct Answer)
D. Non-Hodgkin's lymphoma

Explanation: **Explanation:** The concept of **Prophylactic Cranial Irradiation (PCI)** is based on the "sanctuary site" principle. Certain malignancies have a high propensity to metastasize to the Central Nervous System (CNS), but many systemic chemotherapeutic agents cannot cross the blood-brain barrier in therapeutic concentrations. PCI is administered to eliminate occult micro-metastases in the brain before they become clinically evident. **Why Hodgkin’s Lymphoma (HL) is the correct answer:** Hodgkin’s Lymphoma is primarily a nodal disease that spreads predictably via contiguous lymphatic chains. It has an **extremely low incidence of CNS involvement** (less than 1%). Therefore, there is no clinical indication for prophylactic radiation to the brain in HL patients. **Analysis of Incorrect Options:** * **Small Cell Carcinoma of the Lung (SCLC):** This is the classic indication for PCI. SCLC is highly neurotropic; without PCI, up to 50% of patients develop brain metastases. PCI is indicated for patients with both limited and extensive-stage SCLC who achieve a good response to initial chemo-radiotherapy. * **Acute Lymphoblastic Leukemia (ALL):** The CNS is a major sanctuary site for leukemic cells. While intrathecal chemotherapy has largely replaced radiation in many protocols to reduce long-term toxicity, PCI remains a recognized component of treatment for high-risk ALL to prevent CNS relapse. * **Non-Hodgkin’s Lymphoma (NHL):** Certain aggressive subtypes of NHL (e.g., Burkitt’s lymphoma, Lymphoblastic lymphoma, or Diffuse Large B-cell Lymphoma with high-risk features) carry a significant risk of CNS spread, making CNS prophylaxis (either via intrathecal drugs or PCI) necessary. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Dose for PCI in SCLC:** Usually 25 Gy in 10 fractions. * **Side Effects:** The most significant long-term concern of PCI is neurocognitive decline (memory loss and ataxia). * **Sanctuary Sites:** The two primary sanctuary sites in oncology are the **Brain** and the **Testes**.

Question 3: Osteoradionecrosis most commonly results from which combination of factors?

A. Infection, trauma, and radiation
B. Radiation, trauma, and infection (Correct Answer)
C. Trauma, radiation, and infection
D. None of the above

Explanation: ### Explanation **Osteoradionecrosis (ORN)** is a serious complication of radiation therapy, most commonly affecting the mandible. The pathophysiology is traditionally explained by the **Marx Theory (3-H Principle)**: Hypoxia, Hypocellularity, and Hypovascularity. **1. Why Option B is Correct:** The classic triad responsible for the development of ORN is **Radiation, Trauma, and Infection**. * **Radiation:** Causes endarteritis obliterans, leading to a permanent state of hypoxia and reduced bone vitality. * **Trauma:** Often in the form of a tooth extraction or ill-fitting dentures, it acts as the inciting event that breaks the mucosal barrier. * **Infection:** Once the barrier is breached, secondary infection and microbial colonization occur in the non-vital bone, leading to non-healing necrosis. **2. Why Other Options are Incorrect:** While Options A and C contain the same three elements, the sequence in Option B reflects the **chronological pathophysiology** generally accepted in clinical oncology: Radiation therapy creates the vulnerable environment, Trauma provides the trigger, and Infection complicates the healing process. In the context of NEET-PG, the "Radiation-Trauma-Infection" sequence is the standard academic description of the triad. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most Common Site:** The **Mandible** (due to its higher bone density and lower vascularity compared to the maxilla). * **Marx Classification:** Used to stage ORN based on response to Hyperbaric Oxygen (HBO) therapy. * **Prevention:** All necessary dental extractions should be completed at least **2–3 weeks before** starting radiation therapy. * **Treatment:** Management includes antibiotics, debridement, and **Hyperbaric Oxygen (HBO)** therapy to stimulate angiogenesis.

Question 4: What is the standard treatment of whole-brain radiotherapy (WB) for brain Metastasis?

A. 20 grays (Gy) in 10 fractions
B. 30 grays (Gy) in 10 fractions (Correct Answer)
C. 30 grays (Gy) in 5 fractions
D. 15 grays (Gy) in 10 fractions

Explanation: ### Explanation **Standard Treatment Protocol** Whole-brain radiotherapy (WBRT) is a cornerstone in the palliative management of multiple brain metastases. The goal is to achieve a balance between tumor control and the preservation of neurocognitive function. The **standard fractionation schedule is 30 Gy delivered in 10 fractions** (3 Gy per fraction) over two weeks. This regimen is preferred because it provides an optimal therapeutic ratio, effectively reducing intracranial pressure and neurological symptoms while minimizing long-term radiation-induced leukoencephalopathy. **Analysis of Options** * **Option A (20 Gy in 10 fractions):** This dose is sub-therapeutic for most solid tumor metastases. While it uses a standard number of fractions, the total dose is insufficient for durable local control. * **Option C (30 Gy in 5 fractions):** This represents "hypofractionation" (6 Gy per fraction). While sometimes used in patients with a very poor prognosis (short life expectancy), it carries a significantly higher risk of acute and late neurological toxicity due to the high dose per fraction. * **Option D (15 Gy in 10 fractions):** This dose is far below the clinical threshold required to treat metastatic disease and is not a recognized standard protocol. **High-Yield Clinical Pearls for NEET-PG** * **Indications:** WBRT is typically indicated for patients with >3–4 metastases or those not suitable for Stereotactic Radiosurgery (SRS). * **Hippocampal Sparing:** Modern WBRT techniques often use "Hippocampal Sparing" to reduce memory decline. * **Steroid Adjunct:** Dexamethasone is usually administered alongside WBRT to reduce vasogenic edema caused by the tumors and the radiation itself. * **Alternative Schedule:** 20 Gy in 5 fractions is another accepted short-course regimen for patients with poor performance status.

Question 5: Maximum damage to the skin is caused by which type of radiation therapy?

A. Super voltage X-ray therapy
B. Mega voltage X-ray
C. Orthovoltage X-ray (Correct Answer)
D. Cobalt-60

Explanation: **Explanation:** The degree of skin damage in radiation therapy is primarily determined by the **"Skin Sparing Effect."** This phenomenon depends on the energy of the radiation beam and the depth at which the maximum dose ($D_{max}$) is deposited. **Why Orthovoltage is the Correct Answer:** Orthovoltage X-rays operate at a relatively low energy range (typically **200–500 kV**). Because of this low energy, the maximum dose ($D_{max}$) is deposited almost immediately at the **skin surface**. Since the skin receives 100% of the prescribed dose, it suffers the most significant damage, leading to side effects like erythema, desquamation, and permanent scarring. **Analysis of Incorrect Options:** * **Supervoltage (500–1000 kV) & Megavoltage (>1 MV) X-rays:** As the energy of the X-ray increases, the $D_{max}$ shifts deeper into the tissues (e.g., for a 6 MV beam, $D_{max}$ is at 1.5 cm). This results in a lower dose at the surface, providing a significant skin-sparing effect. * **Cobalt-60:** This is a form of megavoltage therapy (average energy 1.25 MeV). Its $D_{max}$ occurs at **0.5 cm** below the skin surface, meaning it spares the skin significantly more than orthovoltage. **High-Yield Clinical Pearls for NEET-PG:** * **Skin Sparing Effect:** The higher the energy of the photon beam, the deeper the $D_{max}$, and the greater the skin sparing. * **$D_{max}$ Values to Remember:** * **Orthovoltage:** 0.0 cm (Surface) * **Cobalt-60:** 0.5 cm * **4 MV:** 1.0 cm * **6 MV:** 1.5 cm * **10 MV:** 2.5 cm * **Clinical Use:** Orthovoltage is now rarely used except for very superficial lesions (e.g., skin cancers) precisely because it lacks skin sparing.

Question 6: Brachytherapy is an internal radiation therapy procedure for treating tumors. Which of the following isotopes is NOT used in brachytherapy?

A. Iodine-125
B. Iodine-131 (Correct Answer)
C. Cesium-137
D. Iridium-192

Explanation: **Explanation:** The core principle of **Brachytherapy** is the placement of radioactive sources either inside or in close proximity to the tumor. This allows for a high dose of radiation to the target tissue with a rapid dose fall-off, sparing surrounding healthy organs. **Why Iodine-131 is the correct answer:** Iodine-131 (I-131) is primarily used in **Systemic Radionuclide Therapy**, not brachytherapy. It is administered orally or intravenously (unsealed source) for the treatment of differentiated thyroid cancer and hyperthyroidism. Because it is distributed through the bloodstream to target thyroid tissue globally, it does not fit the definition of "brachy" (short-distance) localized source therapy. **Analysis of other options:** * **Iridium-192 (Option D):** The most commonly used isotope in modern clinical brachytherapy, especially for High Dose Rate (HDR) procedures (e.g., cervical and breast cancer). It has a high specific activity and a half-life of ~74 days. * **Iodine-125 (Option A):** A low-energy gamma emitter used for **permanent seed implants**, most commonly in prostate cancer (LDR brachytherapy). * **Cesium-137 (Option C):** Historically the gold standard for Low Dose Rate (LDR) brachytherapy in cervical cancer (e.g., Manchester system). While largely replaced by Iridium-192, it remains a classic brachytherapy isotope. **High-Yield Clinical Pearls for NEET-PG:** * **Cobalt-60:** Used in Teletherapy (Bhabhatron/Gamma Knife) and occasionally in HDR brachytherapy. * **Palladium-103:** Another common isotope for permanent prostate seeds. * **Strontium-90:** A pure beta emitter used for superficial brachytherapy (e.g., pterygium in the eye). * **Gold-198:** Historically used as permanent grains/seeds.

Question 7: Which of the following is the most radiosensitive ovarian tumor?

A. Dysgerminoma (Correct Answer)
B. Dermoid cyst
C. Serous cystadenoma
D. Endodermal sinus tumor

Explanation: **Explanation:** **Dysgerminoma** is the most common malignant germ cell tumor of the ovary and is characterized by its extreme **radiosensitivity**. This property is a hallmark of germ cell tumors (similar to its male counterpart, the seminoma). While surgery is the primary treatment to preserve fertility, radiotherapy is highly effective in treating recurrences or metastatic disease because these cells undergo rapid apoptosis when exposed to ionizing radiation. **Analysis of Incorrect Options:** * **Dermoid Cyst (Mature Cystic Teratoma):** This is a benign germ cell tumor containing mature tissues (hair, teeth, sebum). These mature tissues are differentiated and **radioresistant**. * **Serous Cystadenoma:** This is a benign epithelial tumor. Epithelial tumors, in general, are less radiosensitive than germ cell tumors, and benign versions do not require radiation therapy. * **Endodermal Sinus Tumor (Yolk Sac Tumor):** While this is a malignant germ cell tumor, it is highly aggressive and primarily treated with **chemotherapy** (BEP regimen). It is not as exquisitely radiosensitive as Dysgerminoma. **Clinical Pearls for NEET-PG:** * **Tumor Marker:** Dysgerminoma is associated with elevated **LDH** (and occasionally hCG), whereas Endodermal Sinus Tumor is associated with high **AFP**. * **Radiosensitivity Rule:** In the context of "Most Radiosensitive," always look for **Dysgerminoma** (Ovary), **Seminoma** (Testis), or **Ewing’s Sarcoma** (Bone). * **Histology:** Dysgerminoma shows large cells with clear cytoplasm and central nuclei, separated by fibrous septa containing lymphocytes.

Question 8: Mould therapy is used in the treatment of:

A. Pelvic cancer
B. Lung cancer
C. Prostate cancer
D. Skin cancer (Correct Answer)

Explanation: **Explanation:** **Mould therapy** is a form of **surface brachytherapy** where radioactive sources are placed in a customized applicator (the "mould") that is applied directly to the surface of the body. 1. **Why Skin Cancer is Correct:** Mould therapy is specifically designed for treating superficial lesions. The radioactive sources (commonly Iridium-192 or Cesium-137) are held at a short, fixed distance from the skin. This allows for a high dose of radiation to be delivered to the tumor while ensuring a rapid dose fall-off, which protects the deeper, healthy underlying tissues. It is most commonly used for cancers of the **skin (e.g., Basal Cell Carcinoma, Squamous Cell Carcinoma)**, lip, or hard palate. 2. **Why Other Options are Incorrect:** * **Pelvic and Prostate Cancer:** These involve deep-seated tumors. They are typically treated with **Intracavitary brachytherapy** (e.g., cervical cancer), **Interstitial brachytherapy** (needles inserted into the prostate), or External Beam Radiation Therapy (EBRT). Moulds cannot reach these depths. * **Lung Cancer:** This requires EBRT or occasionally **Intraluminal brachytherapy** (via bronchoscopy). A surface mould would be ineffective for internal thoracic structures. **High-Yield Clinical Pearls for NEET-PG:** * **Brachytherapy Types:** * **Surface (Moulds):** Skin, ear, eye. * **Interstitial:** Breast, Prostate, Tongue (using needles/wires). * **Intracavitary:** Cervix, Endometrium (using Tandem and Ovoids). * **Intraluminal:** Esophagus, Bronchus. * **Inverse Square Law:** The rapid dose fall-off in mould therapy is governed by the inverse square law, making it ideal for superficial treatment. * **Customization:** Moulds are often made of dental acrylic or thermoplastic materials to fit the patient's specific anatomy perfectly.

Question 9: Which radiation therapy modality utilizes the concept of "remote afterloading"?

A. Brachytherapy (Correct Answer)
B. Proton beam therapy
C. Electron beam therapy
D. Cyberknife therapy

Explanation: **Explanation:** **Brachytherapy** is the correct answer because it involves placing radioactive sources directly inside or in close proximity to the target tissue. **Remote Afterloading** is a safety technique used in modern brachytherapy (especially High Dose Rate or HDR) where the radioactive source is stored in a shielded safe and mechanically driven through applicators into the patient via computerized remote control. This system minimizes radiation exposure to healthcare personnel, as the source is only "loaded" once the staff has left the room. **Analysis of Incorrect Options:** * **Proton Beam Therapy:** A type of external beam radiotherapy (EBRT) using heavy particles (protons). It is characterized by the "Bragg Peak," allowing for precise dose deposition but does not involve afterloading. * **Electron Beam Therapy:** A form of EBRT used for superficial tumors (e.g., skin cancer). Electrons have a limited range in tissue and do not require internal source loading. * **Cyberknife Therapy:** A form of robotic Stereotactic Radiosurgery (SRS). It delivers high-dose EBRT from many different angles using a miniature linear accelerator mounted on a robotic arm. **High-Yield Clinical Pearls for NEET-PG:** * **Inverse Square Law:** Brachytherapy follows this principle, where the dose falls off rapidly as distance from the source increases, sparing surrounding healthy organs. * **Common Isotopes:** Iridium-192 (most common for HDR afterloading), Cesium-137, and Iodine-125 (permanent seeds for prostate). * **Manchester System:** A classic dosage system used in cervical brachytherapy (Point A and Point B). * **Safety:** Remote afterloading has effectively replaced "manual loading," making brachytherapy significantly safer for oncology nurses and therapists.

Question 10: Hyperfractionated radiotherapy is primarily used in which of the following conditions?

A. Lung cancer (Correct Answer)
B. Melanomas
C. Soft tissue sarcomas
D. All the above

Explanation: **Explanation:** **Hyperfractionated radiotherapy** involves delivering a higher total dose of radiation by using smaller-than-standard doses (fractions) multiple times a day (usually twice). The primary goal is to exploit the difference in repair capacity between rapidly dividing tumor cells and late-responding normal tissues. 1. **Why Lung Cancer is Correct:** Small Cell Lung Cancer (SCLC) is the classic indication for hyperfractionation (e.g., the Turrisi regimen). Because lung tumors have a high growth fraction, giving two fractions a day minimizes "tumor repopulation" during the treatment course. Smaller doses per fraction also spare late-responding normal tissues like the lungs and spinal cord, allowing for a higher total curative dose. 2. **Why Other Options are Incorrect:** * **Melanomas and Soft Tissue Sarcomas:** These are considered **radioresistant** tumors with a low alpha/beta ratio. They respond better to **Hypofractionation** (larger doses per fraction given fewer times). Large fractions are needed to overcome their inherent repair mechanisms and slow cell cycling. * **All of the above:** Incorrect because the biological rationale for hyperfractionation (sparing late tissues while hitting fast-growing tumors) does not apply to slow-growing, radioresistant sarcomas or melanomas. **Clinical Pearls for NEET-PG:** * **Hyperfractionation:** Increased number of fractions, decreased dose per fraction, total dose increased. Best for **rapidly proliferating tumors** (e.g., SCLC, Head and Neck cancers). * **Hypofractionation:** Decreased number of fractions, increased dose per fraction. Best for **slowly proliferating tumors** (e.g., Prostate, Melanoma, Breast). * **Accelerated Fractionation:** Reducing the overall treatment time without changing the dose per fraction (to counter rapid tumor repopulation).

Practice by Chapter

Principles of Radiation Therapy

Practice Questions

Radiation Therapy Equipment

Practice Questions

Treatment Planning Process

Practice Questions

External Beam Radiation Therapy

Practice Questions

Brachytherapy

Practice Questions

3D Conformal Radiation Therapy

Practice Questions

Intensity-Modulated Radiation Therapy

Practice Questions

Image-Guided Radiation Therapy

Practice Questions

Stereotactic Radiosurgery

Practice Questions

Total Body Irradiation

Practice Questions

Palliative Radiation Therapy

Practice Questions

Combined Modality Treatments

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free